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Abstract Exogenous ATP stimulated phospholipase D
(PLD), but not sphingomyelinase in rat submandibular
gland (SMG) acini. PLD activation was dependent upon ex-
tracellular Ca
 
2
 
 
 
 and did not involve intracellular Ca
 
2
 
 
 
 mo-
bilization or phosphoinositide-speciﬁc phospholipase C ac-
tivation. ATP-stimulated PLD was attenuated by inhibition
or downregulation of protein kinase C (PKC). PLD activa-
tion was fully blocked by the cytosolic phospholipase A
 
2
 
(PLA
 
2
 
) inhibitor ONO-RS-082 and partially attenuated by
the selective Ca
 
2
 
 
 
-dependent cytosolic PLA
 
2
 
 inhibitor,
arachidonyl triﬂuoromethylketone (AACOCF
 
3
 
), or by bro-
moenol lactone, an inhibitor of Ca
 
2
 
 
 
-independent cytosolic
PLA
 
2
 
. Magnesium, which decreases the concentration of
ATP
 
4
 
 
 
, and nickel, which blocks nonspeciﬁc cation chan-
nels coupled to purinergic receptors, inhibited PLD activa-
tion by ATP. Using reverse transcription-polymerase chain
reaction and Northern blotting techniques, we demon-
strated that the PLD isoform stimulated by ATP was PLD-2.
Among various ATP analogs, only the P2Z/P2X
 
7
 
 purinergic
receptor agonist benzoyl-benzoyl ATP stimulated PLD-2.
The response to ATP was inhibited by the nonselective P2X
purinergic antagonist suramin and by oxidized ATP, a po-
tent P2Z/P2X
 
7
 
 receptor antagonist.  It is concluded that
in rat SMG acinar cells, PLD-2 is upregulated by exogenous
ATP through a mechanism involving Ca
 
2
 
 
 
 inﬂux, cytosolic
 
PLA
 
2
 
, and PKC. Also, the data suggest an involvement of
 
P2X
 
7
 
 receptors in PLD-2 stimulation by ATP.—
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Extracellular ATP can regulate a wide range of physio-
logical functions. In most cells, the cytoplasmic concentra-
tion of ATP is in the millimolar range, but in storage gran-
ules of platelets, the concentrations of ATP and ADP can
be as high as 1 M (1). Under conditions of platelet activa-
tion or cell breakage, signiﬁcant portions of ATP can be
released into the extracellular environment so that the
concentrations of pericellular ATP can easily reach the
high micromolar range. The effects elicited by ATP ap-
pear to be mediated through speciﬁc P2-purinergic recep-
tors (2). These receptors are currently classiﬁed into two
major groups. The ﬁrst group includes the metabotropic
P2Y receptors, which are proteins with seven transmem-
brane domains that are coupled to guanine 5
 
 
 
-triphos-
phate (GTP) binding proteins (G-proteins). Agonist stim-
ulation of P2Y receptors causes intracellular Ca
 
2
 
 
 
mobilization through the hydrolysis of phosphoinositides
(PI) by phospholipase C (PLC) (3, 4). The second group
includes the ionotropic P2X receptors, which have two
transmembrane domains. Agonist stimulation of these re-
ceptors induces the formation of nonspeciﬁc cation chan-
nels (5–8). Up to now, seven P2Y receptors and eight P2X
receptors have been cloned (9–11). Among the P2X re-
ceptors, the P2X
 
7
 
 receptor is unique in that its activation
leads not only to the formation of a nonspeciﬁc cation
channel but also to large pores. It was previously termed
P2Z and therefore it is known as the P2Z/P2X
 
7
 
 receptor
 
Abbreviations: AACOCF
 
3
 
, arachidonyl triﬂuoromethylketone;
BEL, (E)-6-(bromoethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-
one (bromoenol lactone); Bz-ATP, 2
 
 
 
,3
 
 
 
-
 
O
 
-(benzoyl-benzoyl)adenosine
5
 
 
 
-triphosphate; cPLA
 
2
 
, calcium-dependent cytosolic phospholipase
A
 
2
 
; DAG, diacylglycerol; HBS, HEPES-buffered saline; iPLA
 
2
 
, calcium-
independent cytosolic phospholipase A
 
2
 
; PA, phosphatidic acid; PC,
phosphatidylcholine; PI-PLC, phosphatidylinositol-speciﬁc phospholi-
pase C; PKC, protein kinase C; PLD, phospholipase D; PMA, 4
 
 
 
-phor-
bol 12-myristate 13 acetate; RT-PCR, reverse transcription-polymerase
chain reaction; SMG, submandibular gland.
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(7, 11). Although ATP can increase the permeability of
cells to a variety of cations, including Na
 
 
 
, K
 
 
 
, or Ba
 
2
 
 
 
,
the channel shows considerable selectivity for Ca
 
2
 
 
 
 (3).
The stimulation of P2Z/P2X
 
7
 
 receptors leads to phospho-
lipase D (PLD) activation in human lymphocytes (3) and
in osteoblast-like cells (12). Activation of PLD is of partic-
ular interest because it increases the intracellular concen-
tration of phosphatidic acid (PA), which is bioactive (13–
15). In addition, PA is the precursor of important second
messengers, as it can give rise to lysoPA by the action of
PLA
 
2
 
, or to diacylglycerol (DAG) when it is acted upon by
phosphatidate phosphohydrolases. Two isoforms of mam-
malian PLD have been identiﬁed in mammalian cells and
then cloned. PLD-1 can be activated by monomeric G-pro-
teins of the ADP-ribosylation factor (ARF) and Rho fami-
lies, and protein kinase C (PKC), whereas PLD-2 shows lit-
tle or no response to the known activators of PLD-1 (16).
There is also evidence for the existence of a distinct PLD
that is activated by oleate (16, 17). However, cloning of
the oleate-dependent PLD isoform has not yet been re-
ported.
The present study was undertaken to investigate which
of the known PLDs was sensitive to activation by ATP, and
to establish the underlying mechanism(s) for this activa-
tion in submandibular gland (SMG) acini. The possible
involvement of P2Z/P2X
 
7
 
 receptors in this process was
also examined.
MATERIALS AND METHODS
 
Materials
 
ATP (sodium salt), adenosine-5
 
 
 
-
 
O
 
-(3-thiotriphosphate (AT-
P
 
 
 
S), BSA (BSA, fraction V), and collagenase P were from Boeh-
ringer Mannheim (Mannheim, Germany). 2,3-Dialdehyde ATP
(periodate-oxidized ATP). Adenosine 5
 
 
 
-diphosphate (ADP),
benzoyl-benzoyl ATP (Bz-ATP), cytidine 5
 
 
 
-triphosphate (CTP),
digitonin, DNase I (from bovine pancreas), EGTA, GTP, HEPES,
PA, phosphatidylcholine (PC), 4
 
 
 
-phorbol 12-myristate 13 ace-
tate (PMA), sphingomyelinase (from 
 
Staphylococcus aureus
 
), uri-
dine 5
 
 
 
 triphosphate (UTP), 
 
  
 
-methylene ATP (
 
  
 
-mATP),
mega-10 detergent, and fatty acid standards were from Sigma (St.
Louis, MO). [
 
3
 
H]myristic acid (60 Ci/mmol) was supplied by
American Radiolabeled Chemicals, Inc. (St. Louis, MO).
[
 
3
 
H]oleic acid (5 Ci/mmol) was from NEN (Boston, MA). Per-
coll was from Pharmacia (Uppsala, Sweden). The Dowex AG1-X8
columns were from Bio-Rad (Hercules, CA). Phosphatidyletha-
nol standard was supplied by Avanti Polar-lipids (Alabaster, AL).
Fura-2-acetoxymethylester (AM) was from Molecular Probes (Eu-
gene, OR). Suramin was supplied by Alexis Biochemicals
(Woburn, MA). Chelerythrine was from Calbiochem (La Jolla,
CA). C
 
2
 
-ceramide was from Matreya, Inc. (Pleasant Gap, PA).
The thin layer chromatography (TLC) plates of silica gel 60 were
from Macherey-Nagel (Düren, Germany). Other chemicals were
the highest grade available and their sources have been de-
scribed (8).
 
Preparation of SMG acini
 
Acinar cells were isolated from male Sprague-Dawley rats
(200–250 g) that were given free access to water and food. The
rats were killed by exposure to diethylether atmosphere. SMGs
were then immediately dissected and minced in about 0.2 ml of
HEPES-buffered saline (HBS) containing 96 mM NaCl, 6 mM
KCl, 2.5 mM NaH
 
2
 
PO
 
4
 
, 11 mM glucose, 5 mM sodium pyruvate,
5 mM sodium fumarate, 5 mM sodium glutamate, 1% (v/v) glu-
tamine-free amino acid mixture (Life Technologies, Inc.), and
24.5 mM HEPES. The pH was adjusted to 7.4 with NaOH. The
medium was supplemented with 0.125% (w/v) BSA. A homoge-
neous suspension of acinar cells was obtained essentially as de-
scribed (8) with minor modiﬁcations. The minced tissue was
then incubated in 10 ml HBS medium containing 1.5 mg of col-
lagenase P (1.52 U/mg) at 37
 
 
 
C for 20 min under constant shak-
ing (about 90 cycles/min). After the ﬁrst 10 min of incubation,
the tissue was aspirated 10 times with a 10 ml glass pipette. This
process was repeated at the end of the incubation time and was
followed by aspiration of the cell suspension with 5 ml and 2 ml
glass pipettes. The cell suspension was then washed three times
with an isotonic saline solution, resuspended in 10 ml of collage-
nase-free HBS and further incubated for 10 min in the presence
of 0.06 mg/ml of DNAase I (420 U/mg). The crude suspension
was aspirated again several times with a 2 ml glass pipette, ﬁl-
tered through a nylon mesh, and washed three times with saline
solution. To separate the acini from the ducts, the cell suspen-
sion was resuspended in 4 ml of HBS and distributed in two
tubes containing 6 ml of an isotonic Percoll solution (40%). The
cell suspension was carefully layered on top of the Percoll solu-
tion. The tubes were then centrifuged at 4,000 
 
g
 
 at 4
 
 
 
C for 10
min. The acini sedimented through the Percoll solution,
whereas ductal cells remained on the top. The acinar cells were
then recovered and washed three times with the isotonic saline
solution. The ﬁnal pellet was resuspended in HBS medium and
kept at 4
 
 
 
C for 10 min before being used in the experiments.
 
Cell culture
 
Raw 264.7 macrophages were grown in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) containing penicillin and streptomy-
cin supplemented with 10% fetal bovine serum (FBS). Then,
they were washed three times in DMEM, preincubated for 1 h in
DMEM containing 1% FBS with or without inhibitors prior to ad-
dition of agonists, and then incubated for the appropriate times
before being harvested.
 
Assay of PLD activity
 
PLD was determined in vivo by measuring the production of
[
 
3
 
H]phosphatidylethanol, which is the product of its transphos-
phatidylation activity when cells containing [
 
3
 
H]PC are incu-
bated in the presence of ethanol (18). Rat SMG acini were incu-
bated for 2 h with HBS medium containing 0.125% BSA, 0.5 mM
Ca
 
2
 
 
 
, and 10 
 
 
 
Ci of [
 
3
 
H]myristate/ml to label cell PC. The ra-
dioactive medium was then removed by centrifugation and the
cells washed three times with isotonic saline solution and resus-
pended in HBS medium with 1.5 mM Ca
 
2
 
 
 
. Ethanol, at a ﬁnal
concentration of 1%, was added 5 min prior to the addition of
agonists and the cells incubated at the times indicated. This con-
centration of ethanol gave maximal formation of phosphatidyl-
ethanol, as shown in the results section, with no toxicity for the
cells. The acini were incubated with the agonists for varying
times at 37
 
 
 
C with constant shaking (about 90 cycles/min) in
plastic vials in a ﬁnal volume of 400 
 
 
 
l. Aliquots (100 
 
 
 
l) were
then withdrawn from each vial in triplicate and lipids were ex-
tracted as described by Bligh and Dyer (19), except that 2 M KCl
in 0.2 M HCl was added to the extraction mixture instead of wa-
ter for separation of phases. Chloroform phases were then vac-
uum-dried in an automatic Speed Vac concentrator (Savant
AS290) and resuspended in 50 
 
 
 
l chloroform. Lipids were sepa-
rated by TLC using 20 
 
 
 
 20 cm silica gel 60-coated aluminum
plates. TLC plates were developed for 50% of their lengths with
chloroform-methanol-acetic acid (9:1:1, v/v/v) and then dried. 
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The plates were then redeveloped for their full lengths with pe-
troleum ether-diethylether-acetic acid (60:40:1, v/v/v). The posi-
tion of the lipids was identiﬁed after staining with I
 
2
 
 vapor by
comparison with authentic standards. The silica gel containing
radioactive lipids was quantitated by liquid scintillation counting
after scraping from the plates.
The effect of GTP
 
 
 
S and recombinant ARF1 on PLD was ex-
amined in cells permeabilized by treatment with digitonin (50
 
 
 
g/ml) in a ﬁnal concentration of 1% ethanol according to Li et
al. (20).
To assay the oleate-dependent PLD activity in vitro, we ﬁrst ob-
tained puriﬁed PC from SMG acini that were labeled with
[
 
3
 
H]myristate (20 
 
 
 
Ci/ml) for 4 h. The lipids were extracted as
indicated above. [
 
3
 
H]PC was puriﬁed by TLC on silica gel 60 us-
ing chloroform-methanol-water (65:35:7, v/v/v) and visualized
by iodine vapor. [
 
3
 
H]PC was eluted from the TLC plates by wash-
ing the silica gel three times with chloroform-methanol-acetic
acid-water (50:39:1:10, v/v/v/v). Eluates were combined and
phases separated by adding 1 ml of water. The organic phase
containing the [
 
3
 
H]PC was washed twice with 4 ml of methanol-
water (1:1, v/v) and then dried. Assays were performed essentially
according to Lee et al. (17). Brieﬂy, the assay mixture consisted of
60 
 
 
 
M [
 
3
 
H]PC (80,000 dpm), 1 mM PA, 2.5 mM oleate, 10 mM
CaCl
 
2
 
, 25 mM potassium ﬂuoride, 2.5 mM MgCl
 
2
 
, 0.05% (w/v)
Mega-10, 1.5% ethanol, 50 mM HEPES buffer (pH 7.0) and 100–
200 
 
 
 
g of homogenate or microsomal or cytosolic fractions in a to-
tal volume of 100 
 
 
 
l. The reaction mixture was incubated for 90
min at 30
 
 
 
C. The lipid extraction and measurement of [
 
3
 
H]phos-
phatidylethanol radioactivity was performed as described above.
 
Assay of phosphatidylinositol-speciﬁc phospholipase
C activity
 
Phosphatidylinositol-speciﬁc phospholipase C (PI-PLC) was
determined essentially as described (21). Brieﬂy, SMG acinar
cells obtained from one rat were washed with 10 ml of an iso-
tonic saline solution and resuspended in 3 ml of HBS containing
1% BSA and 1 mM Ca
 
2
 
 
 
. Cells were then incubated for 90 min at
25
 
 
 
C in the presence of 25 
 
 
 
Ci/ml of 
 
myo
 
-[2-
 
3
 
H]inositol to label
cell phosphoinositides. The acini were then washed twice with 10
ml of HBS in the absence of radioactive inositol and pre-incu-
bated in 4.5 ml of HBS containing 0.125% BSA and 1 mM Ca
 
2
 
 
 
for 10 min at 37
 
 
 
C in the presence of 10 mM LiCl. Aliquots (100
 
 
 
l) were incubated in a ﬁnal 500 
 
 
 
l of HBS medium in the pres-
ence or in the absence of ATP for 10 min. Samples were centri-
fuged at 10,000 
 
g
 
 for 30 s. Supernatants were discarded, and 500
 
 
 
l of 10% (w/v) ice-cold trichloroacetic acid were added to the
pellet. Samples were spun down for 2 min at 10,000 
 
g
 
, and the su-
pernatants were transferred to glass tubes. The pellets were
washed again with 500 
 
 
 
l of 10% trichloroacetic acid, centri-
fuged, and then pooled. Trichloroacetic acid was then extracted
with water-saturated diethylether. The extracts were neutralized
with 1 M KOH and diluted with 8 ml of 10 mM HEPES and 2 mM
EDTA (pH 7.4). Inositol phosphates were isolated by using
Dowex AG1-X8 columns as described previously (21). The radio-
active samples eluted off the column were quantiﬁed by liquid
scintillation counting.
 
Measurement of Ca
 
2
 
  concentrations
Intracellular Ca2  concentration was determined as described
previously (22). Brieﬂy, 1 ml aliquots of acini suspensions were
incubated at 25 C with 1 ml HBS buffer containing 0.125% (w/
v) BSA, 0.5 mM CaCl2, and 2  M Fura-2/AM. After 45 min, 1 ml
of this suspension was withdrawn, washed with isotonic saline,
and resuspended in 2 ml HBS without amino acids or BSA, and
1 mM Ca2 . Cells were constantly stirred in the cuvette of a ﬂuo-
rimeter (SLM Aminco Bowman Series 2). The excitation wave-
length was switched every second from 340 nm to 380 nm (slit
width 4 nm), and the light emitted at 510 nm (slit width 4 nm)
was recorded. The voltage of the photomultiplier was 700–750 V.
At the beginning of each assay, the signal observed after excita-
tion at 340 nm was arbitrarily set at 50% maximal scale by adjust-
ing the voltage. At the end of each assay, the traces were cali-
brated with the successive addition of 0.5 mM digitonin and 40
mM EGTA in Tris buffer (pH 8.5). Autoﬂuorescence was mea-
sured in the presence of NiCl2 (250 mM). The values obtained
were subtracted from all the data before calculation of ratios.
Ca2  concentrations were estimated by the ratio method (21),
using a Kd value of 263 nM.
RNA extraction and reverse transcription-polymerase 
chain reaction
Acinar and ductal cells were puriﬁed through a Percoll gradi-
ent three times in order to minimize cellular contamination. To-
tal RNA was extracted from cellular fractions with TRIzol Re-
agent (Invitrogen), based on the Chomczynski and Sacchi
method (23), according to the manufacturer’s instructions.
First-strand cDNA was synthesized from 2  g of RNA using Su-
perScript First-Strand Synthesis System for reverse transcription-
polymerase chain reaction ( RT-PCR), and ampliﬁcation reac-
tions were performed with Platinum PCR Supermix (Invitrogen)
in accordance with the supplier’s instructions. Speciﬁc primers
for detection of P2Z/P2X7 transcripts were designed exactly as
described previously (8). Sequences of primers used for the RT-
PCR detection of PLD isoforms (Genset, FR) and ampliﬁcation
conditions for PLD-1b and PLD-2 were performed according to
Gibbs and Meier (24). PLD-1a primers were designed using the
Genetics Computer Group program GCG Primer taking into ac-
count the difference of 38 amino acids with its splice variant (see
sequences below). Conditions for PCR were: 94 C for 1 min,
56 C for 1.5 min, and 72 C for 2 min for 30 cycles (PLD-1a and
PLD-1b); 94 C for 1 min, 56 C for 1 min, and 60 C for 1.5 min
for 40 cycles (PLD-2). Ampliﬁed products were analyzed by elec-
trophoresis in 2% agarose gels stained with ethidium bromide.
In order to test for the presence of contaminating genomic DNA
(gDNA), the same cDNA samples were subjected to PCR with  -
actin primers (Clontech, CA). Since these primers span three in-
trons, contaminating gDNA can be detected as a 1,440 bp PCR
product in addition to a 764 bp product, the latter correspond-
ing to expressed RNA.
 
Preparation of cDNA probes
RT-PCR products were puriﬁed using the Gel Extraction Sys-
tem kit (Invitrogen) after checking their identity with restriction
enzymes. Twenty-ﬁve nanograms of PLD1a or PLD1b cDNA
probes were labeled with [ -32P]dCTP (3,000 Ci/mmol; Amer-
sham Pharmacia Biotech) using a Random Primed DNA Label-
ing Kit from Boehringer Mannheim. The radiolabeled probes
were puriﬁed by chromatography to remove the unincorporated
radionucleotides.
Gene and Accession
Number (GenBank)
Primers
Coordinates Primer Sequence (5 →3 )
PCR
Product 
(bp)
PLD1a - AB000778 886-905
2,025-2,044
GGGGGACACAGGATACCAGG
GGCCCTGCTCAGACTCACTG
1,159
PLD1b - AB000779 871-890
1,929-1,948
GGGGGACACAGGATACCAGG
GGATGGAGCCGGTGTTGGAG
1,078
PLD2 - D88672 2,042-2,063
2,352-2,373
TCAAGGCCAGATACAAGATACC
CACGTAGACTCGGAAACACTGC
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Northern blot analysis
RNA samples (40  g/lane) were denatured with formamide
and formaldehyde and size-separated by 1.2% agarose gel elec-
trophoresis in MOPS buffer. The RNAs were blotted onto a ny-
lon membrane (Hybond-N, Amersham Pharmacia Biotech),
UV-crosslinked, and hybridized by standard methods (25). The
expression of each gene was visualized and quantitated by a Mo-
lecular Imager FX System and QuantityOne software (Bio-Rad
laboratories). Blots were stripped by washing at 65 C for 15 min
in TE buffer with 0.1% SDS prior to reprobing.
Measurement of ceramide production
[3H]ceramides were determined by scraping the ceramides
from the same thin-layer plate as that used for isolating
[3H]phosphatidylethanol and quantifying the radioactive cer-
amides by liquid scintillation counting, as indicated previously
(26). The identity of the ceramide was conﬁrmed by cochro-
matography with authentic ceramides.
Statistical analysis
Unless stated otherwise, results are expressed as means   SEM
of the number of experiments that are indicated performed in
triplicate. Statistical signiﬁcance of the difference between
means of control and experimental conditions was assessed with
Student’s paired t-test. Values of P   0.05 were considered signiﬁ-
cant.
RESULTS
ATP stimulates PLD activity in rat SMG acini
PLD was determined by measuring the accumulation of
[3H]phosphatidylethanol as indicated in the Materials
and Materials and Methods section. In a ﬁrst set of experi-
ments, we conﬁrmed that [3H]myristic acid was selectively
incorporated into PC, which is the main substrate for PLD
in mammalian tissues (16, 27). Maximal incorporation of
[3H]myristic acid into PC occurred after about 2 h of in-
cubation with the acini. By contrast, [3H]oleic acid was
equally distributed in PC and phosphatidylethanolamine
(data not shown). Exposure of [3H]myristic acid-labeled
rat SMG acini to exogenous ATP in the presence of 1%
ethanol caused a substantial increase in the accumulation
of [3H]phosphatidylethanol, which was time and concen-
tration dependent (Fig. 1). Maximal PLD activation by
ATP was attained after about 1.5 mM. Concentrations of
ATP above 10 mM, although not toxic for the acini, were
less effective in activating PLD (data not shown). The ﬁnal
concentration of ethanol was kept at 1% in all of the ex-
periments, as this concentration provided maximal fold
increase in the accumulation of phosphatidylethanol rela-
tive to control values (Fig. 2). The extent of PLD activa-
tion varied among different experiments, but there was
consistency in cell responsiveness for the SMG acini of in-
dividual animals. PLD stimulation by ATP was 4.6   0.3
(mean   SEM of 50 independent experiments performed
in triplicate).
An important signaling pathway that could be impli-
cated in the stimulation of PLD is the sphingomyelinase
(SMase) pathway. Stimulation of SMase activity generates
ceramide and phosphorylcholine from sphingomyelin
(SM). Although ceramides are potent inhibitors of PLD
(14, 18, 26, 28–33), they have been shown to stimulate this
enzyme activity in human ﬁbroblasts (34). Ceramides can
also be generated by de novo synthesis, and could lead to
stimulation of PLD via conversion to sphingosine by the
action of ceramidases. Sphingosine, in turn, can be phos-
phorylated to sphingosine 1-phosphate, and both sphin-
gosine and sphingosine 1-phosphate are potent stimu-
lators of PLD in different cell types (13, 26, 34–38).
However, ATP did not induce ceramide accumulation
when the acini were incubated for up to 3 h in the pres-
ence of increasing concentrations of this nucleotide (1–10
mM). In addition, sphingosine failed to stimulate PLD
when it was added to the cells at 5 or 10  M for up to 3 h,
and sphingosine 1-phosphate was a weak activator of PLD
in the acini. Maximal activation by sphingosine 1-phos-
phate was attained at 5  M, and this stimulated PLD by
about 1.71   0.15-fold (mean   SEM of three indepen-
dent experiments, P   0.05) over the control value. Also,
incubation of the acini for up to 3 h with 5–100  M of the
short-chain ceramide N-acetylsphingosine ([C2]ceramide),
or with exogenous bacterial SMase (up to 1 U/ml), which
generates long-chain ceramides at the plasma membrane
of cells, did not induce PLD activation (data not shown).
Furthermore, and in agreement with previous work (18,
26), [C2]ceramide (100  M, in the presence of 0.125%
BSA) inhibited ATP-stimulated PLD by about 77   8%
(mean   SEM of three independent experiments, P  
0.01), and pretreatment of the acini for 2 h with exoge-
nous SMase (1 U/ml) resulted in 56   16% (mean  
SEM of four independent experiments, P   0.05) inhibi-
Fig. 1. Stimulation of phospholipase D (PLD) activity by ATP in
submandibular gland (SMG) acini. Cells were labeled with
[3H]myristate (10  Ci/ml) for 2 h in HEPES-buffered saline (HBS)
medium containing 0.125% BSA. Acini were then treated with 1.5
mM ATP for various times, as indicated (left panel) or with increas-
ing concentrations of ATP for 30 min (right panel) in the presence
of 1% ethanol. [3H]phosphatidylethanol formation was deter-
mined by separating the lipids by thin-layer chromatography (TLC)
and processed as described in the Materials and Methods section.
The results were calculated as a percentage of the radioactivity
present in [3H]phosphatidylethanol compared with that in total
lipids, and then expressed as the fold-stimulation relative to incuba-
tions in the absence of ATP. For control incubations, typical radio-
activity measurements were 495   61 dpm (mean   SEM, n   44)
per 100  l cell aliquot in phosphatidylethanol, and 647,595  
37,310 dpm (mean   SEM, n   44) in total lipids. Results are ex-
pressed as the means   SEM of four independent experiments.1248 Journal of Lipid Research Volume 43, 2002
tion of this enzyme activity. Therefore, it can be con-
cluded that PLD activation by ATP is not mediated
through the generation of ceramide or its further metabo-
lism to sphingosine or sphingosine 1-phosphate.
Role of Ca2  in the stimulation of PLD by ATP
in SMG acini
ATP can stimulate both intracellular Ca2  mobilization
and Ca2  inﬂux. The former action can be induced by rel-
atively low concentrations of ATP (10–100  M), whereas
the latter requires higher ATP concentrations (0.5–1.5
mM) (21, 22). Low concentrations of ATP (10–100  M)
can also increase the levels of inositol trisphosphate (IP3),
suggesting that a phosphatidylinositol-speciﬁc phospholi-
pase C (PI-PLC) is involved in this process (21, 22). How-
ever, these relatively low concentrations of ATP failed to
stimulate PLD in the acini (Fig. 1, right panel). By con-
trast, 1 mM ATP allowed extracellular Ca2  (kept at 1
mM) to enter the cells, causing a rise in the intracellular
concentration of this cation from 85.3   5.6 nM to 175  
6.3 nM (mean   SEM of 10 independent determinations)
after 10 s. Interestingly, this higher concentration of ATP
failed to stimulate PI-PLC [(21) and unpublished observa-
tions]. PLD stimulation by ATP increased with increasing
concentrations of extracellular Ca2  (Fig. 3), and addi-
tion of EGTA (5 mM) to the incubation medium com-
pletely blocked this effect. Taken together, these results
indicate that the activation of PLD by ATP requires Ca2 
inﬂux from the external environment, but is independent
of intracellular Ca2  mobilization.
Role of PKC in the stimulation of PLD by ATP
in SMG acini
Several lines of evidence indicate that PKC plays a ma-
jor role in agonist stimulation of PLD activity (16). PMA
(100 nM), a well established PKC activator, doubled the
activity of PLD in SMG acini, and this stimulation was
blocked by the selective PKC inhibitor chelerythrine (Fig.
4, right panel). The signaling cascade leading to activa-
tion of PLD via PKC usually involves the initial stimulation
of PI-PLC isozymes, which hydrolyze phosphatidylinositol
bisphosphate to generate DAG and inositol 1,4,5-trisphos-
phate (IP3)-mediated release of intracellular Ca2 . How-
ever, although we found that concentrations of ATP that
are able to activate PLD failed to stimulate the genera-
tion of IP3 or the mobilization of intracellular Ca2  (not
shown), PKC may still be involved in PLD activation
through mechanisms that are independent of PI-PLC.
This possibility was evaluated by downregulating PKC with
prolonged incubations of the acini with PMA. Although
PKC downregulation is a long-term process, it has been
demonstrated that in rat SMG slices, it occurs after 2 h
treatment with phorbol esters (39). We observed that after
4 h preincubation with PMA (500 nM), the acini lost their
sensitivity to rapid activation of PLD by PMA, and the
stimulation of PLD by ATP was markedly reduced (Fig. 4,
left panel). Although this inhibitory effect on PLD was in-
complete, no further inhibition of this enzyme activity was
attained by increasing the incubation time of the acini
with PMA for up to 5 h. Incubation times longer than 5 h
were not considered for experiments because the viability
of the cells started to decrease after this time, as assessed
by lactate dehydrogenase release into the medium. There-
fore, the role of PKC on ATP-stimulated PLD was further
evaluated with chelerythrine. This PKC inhibitor potently
blocked the activation of PLD by ATP (Fig. 4, right panel).
Similar results were obtained with the selective PKC inhib-
itor Ro-32-0432 (1  M) (data not shown). Taken together,
these results suggest an involvement of PKC in the stimu-
lation of PLD by ATP in SMG acini.
Fig. 2. Effect of increasing concentrations of ethanol on phos-
phatidylethanol formation by ATP in SMG acini. Cells were labeled
and treated as indicated in Fig. 1, except that they were incubated
for 30 min in the absence (circles) or presence (squares) of 1.5 mM
ATP and increasing concentrations of ethanol, as indicated. Values
were calculated as a percentage of the radioactivity present in
[3H]phosphatidylethanol compared with that in total lipids. Results
are the mean   SEM of three independent experiments.
Fig. 3. Effect of extracellular Ca2  on the activation of PLD by
ATP in SMG acini. Cells were labeled and treated as indicated in
Fig. 1, except that they were stimulated for 30 min with 1.5 mM
ATP and 1% ethanol in the presence of increasing concentrations
of Ca2 , as indicated. Results are the mean   SEM of three inde-
pendent experiments.Pérez-Andrés et al. PLD-2 activation by ATP 1249
There is also evidence for an involvement of tyrosine
phosphorylation in the regulation of PLD activity [Re-
viewed by Exton (16)]. In particular, vanadate, which in-
hibits tyrosine phosphatases, has been shown to stimulate
basal PLD potently and to enhance agonist-stimulated
PLD activation in different cell types (16, 30, 31, 40–42).
However, in SMG acini, tyrosine phosphorylation may
not be a major mechanism for PLD activation, as vana-
date (200  M) only activated PLD by about 30   12%
(means   SEM of ﬁve independent experiments), and
did not enhance the stimulation of PLD by ATP. In addi-
tion, the potent tyrosine kinase inhibitor genistein (100
 M) failed to attenuate ATP-stimulated PLD activity
(data not shown).
Identiﬁcation of PLD-2 in rat SMG acini
To identify the PLD isoforms that were susceptible to
activation by ATP, puriﬁed RNA from SMG acini or ducts
was used to speciﬁcally amplify PLD-1 and PLD-2 se-
quences by RT-PCR. Since PLD-1 can be expressed as two
splice variants, PLD-1a and PLD-1b, the latter lacking 38
amino acids (43), speciﬁc primers were used to amplify
each of these transcripts independently. Figure 5 (upper
panel) shows that ductal cells express both PLD-1a and
PLD-1b mRNAs, whereas none of these transcripts could
be detected in the acini. However, it is noteworthy that RT-
PCR reactions carried out with speciﬁc primers for PLD-2
revealed that this PLD isoform is expressed in both acinar
and ductal cells (Fig. 5, lower panel). To verify the ab-
sence of PLD-1 mRNA in SMG acini, we performed North-
ern blot analysis with cDNA probes speciﬁc for PLD-1a
and PLD-1b. Figure 6 demonstrates the absence of PLD-1a
and PLD-1b mRNAs in the acini, thereby conﬁrming the
results obtained with RT-PCR. By contrast, ductal cells
show intense bands for the mRNAs of both PLD isozymes.
These observations were further conﬁrmed by using the
small GTP binding protein ARF and GTP S, a nonhydro-
lyzable analog of GTP, on cytosolic and membrane frac-
tions from cells that were permeabilized with 50  g/ml of
digitonin. Although soluble PLD activities have been re-
ported, in general, mammalian PLDs appear to be mem-
brane-bound enzymes (44). Furthermore, it is well estab-
lished that ARF is an essential cofactor for activation of
PLD-1, but it is not required for activation of PLD-2 (16,
45, 46). In this regard, we show here that ARF stimulated
PLD activity in the presence of GTP S in membrane frac-
tions of ductal cells, which express both PLD-1 and PLD-2,
but not in membrane fractions of acini, which only ex-
press the PLD-2 isoform (Fig. 7). Also, and in agreement
with other work (20), no PLD activity was detected in cyto-
solic fractions of either ductal or acinar cells in the pres-
ence of ARF and GTP S (data not shown). It can then be
concluded that ductal cells contain both PLD-1 and PLD-2
isoforms, whereas only PLD-2 is present in the acini.
There is evidence for the existence of another mamma-
lian PLD that is distinct from PLD-1 and PLD-2. This PLD
isoform is potently stimulated by oleate, or by other unsat-
urated fatty acids, although to a lesser extent than by ole-
ate (17, 47). The so-called oleate-dependent PLD has
Fig. 4. Involvement of protein kinase C (PKC) in the stimulation
of PLD by ATP. The left panel shows the effect of PKC downregula-
tion on ATP-stimulated PLD activation. SMG acinar cells were la-
beled and treated as indicated in Fig. 1, except that they were pre-
incubated for 4 h in the absence (open bars) or in the presence
(hatched bars) of 500 nM 4 -phorbol 12-myristate 13 acetate
(PMA) to downregulate PKC activity. Cells were then stimulated
with 1.5 mM ATP or 100 nM PMA for 30 min, as indicated. The re-
sults were calculated as a percentage of the radioactivity present in
[3H]phosphatidylethanol compared with that in total lipids, and
then expressed as the fold-stimulation relative to incubations in the
absence of ATP or PMA. Results are the mean   SEM of four inde-
pendent experiments. The right panel shows the effect of the selec-
tive PKC inhibitor chelerythrine on the activation of PLD by ATP.
Cells were preincubated for 30 min with the concentrations of chel-
erythrine that are indicated. The acini were then treated without
(open circles) or with 1.5 mM ATP to stimulate PLD and the incu-
bations continued further for 30 min. As expected, 25  M chel-
erythrine also inhibited the stimulation of PLD by 100 nM PMA
from 2.3   0.1 to 1.4   0.1-fold. The results are the means   SEM
of three independent experiments performed in triplicate.
Fig. 5. Identiﬁcation of PLD isoforms by reverse transcription-
polymerase chain reaction (RT-PCR) in rat SMG cells. Total RNA
(2  g) of SMG acini (A), ducts (D), or vehicle (ø) was subjected to
RT-PCR, as described in the Materials and Methods section. RT-
PCR ampliﬁcations of  -actin mRNA were performed in parallel in
the same experiments as control to verify the integrity of the cDNA
and the absence of contaminating genomic DNA (gDNA). The
numbering on the right corresponds to the size in base pairs of the
amplicons. Data are representative of three independent experi-
ments.1250 Journal of Lipid Research Volume 43, 2002
been puriﬁed from pig lung membranes (48), but to our
knowledge it has not been cloned yet. To determine if ole-
ate-dependent PLD activity was present in SMG acini, cells
were incubated with increasing concentrations of oleate
(0.25–3 mM) for various times up to 2 h. Under these con-
ditions, oleate did not cause any signiﬁcant accumulation
of [3H]phosphatidylethanol, suggesting that SMG acini
lack oleate-dependent PLD. Measurements of PLD activity
were also conducted in vitro to determine if oleate could
stimulate PLD in a cell-free system. Incubation of cell ho-
mogenates with exogenous [3H]PC under optimal condi-
tions for measuring oleate-dependent PLD, in the pres-
ence of ethanol (1.5%) (17), showed no formation of
[3H]phosphatidylethanol, further conﬁrming the lack of
this enzyme activity in SMG acini (data not shown). More
recently, it has been demonstrated that oleate can either
enhance or inhibit PLD-2 activity in different cell types
(41, 49). Therefore, we tested to see whether acinar PLD-
2 activity could be affected by oleate. Figure 8 shows that
oleate (1 mM) completely blocked the stimulation of PLD
by 1 mM ATP or 100 nM PMA in SMG acini. In addition, it
was reported (50) that, unlike PLD-1, the activity of PLD-2
is speciﬁcally regulated by cytosolic phospholipase A2
(PLA2), and we recently demonstrated that ATP stimu-
lates both calcium-dependent cytosolic phospholipase A2
(cPLA2) and calcium-independent cytosolic phospholi-
pase A2 (iPLA2) activities (8). Therefore, experiments
were conducted to determine whether ATP-stimulated
PLD-2 might also involve PLA2 activation in SMG acini. As
expected, the cytosolic PLA2 inhibitor ONO-RS-082
blocked the activation of PLD by ATP completely, suggest-
ing a role for PLA2 in the stimulation of PLD-2 by ATP in
SMG acini (Fig. 9). Because the ONO-RS-082 inhibitor
does not discriminate between cPLA2 or iPLA2 activities,
experiments were carried out with the selective inhibitors,
arachidonyl triﬂuoromethylketone (AACOCF3) and (E)-
6-(bromoethylene)tetrahydro-3-(1-naphthalenyl)-2H-py-
ran-2-one (bromoenol lactone) (BEL), which speciﬁcally
block cPLA2 and iPLA2, respectively. Preincubation of the
acini with optimum concentrations (100  M) of either of
these inhibitors (8) caused partial inhibitions of ATP-acti-
vated PLD, and the stimulation of this enzyme activity was
inhibited further when the cells were preincubated with
Fig. 6. Northern blots for PLD-1 isoform expression in rat SMG
cells. Total RNA (40  g) of SMG acini (A) and ducts (D) was blot-
ted and sequentially hybridized with radiolabeled probes speciﬁc
for PLD-1a and PLD-1b mRNAs, as described in Materials and
Methods. Ethidium bromide staining of agarose gels (lower panel)
demonstrates equal RNA loading in each lane.
Fig. 7. Effect of recombinant ARF and GTP S on PLD activity in
membrane fractions of SMG ductal or acinar cells. SMG cells were
labeled as indicated in Fig. 1. They were then permeabilized with
50  g/ml of digitonin, and the membrane fractions from ducts or
acini were separated from their cytosols according to Li et al. (20).
Recombinant ARF1 (5  M) and GTP S (100  M) were added to
membrane fractions of acini (empty bars) or ducts (ﬁlled bars), as
indicated. PLD activation was assayed over 20 min. Values are mean  
range of two independent experiments. In agreement with other
work (20), recombinant ARF1 had no effect on basal PLD when
added alone.
Fig. 8. Inhibition of ATP- or PMA-stimulated PLD by oleate in
SMG acini. Cells were labeled and treated as indicated in Fig. 1, ex-
cept that they were preincubated for 5 min in the absence (open
bars) or in the presence (solid bars) of 1 mM oleate. Cells were
then stimulated with 1.5 mM ATP or 100 nM PMA for 30 min, as in-
dicated. The results were calculated as a percentage of the radioac-
tivity present in [3H]phosphatidylethanol compared with that in to-
tal lipids, and then expressed as the fold-stimulation relative to
incubations in the absence of ATP or PMA. Results are the mean  
SEM of three independent experiments.Pérez-Andrés et al. PLD-2 activation by ATP 1251
both PLA2 inhibitors simultaneously (Fig. 9). To rule out a
possible direct effect of these inhibitors on PLD, they were
evaluated for speciﬁcity. This was accomplished by chal-
lenging SMG ductal cells with 100  M carbachol, a drug
which does not stimulate PLA2 activity in this cell type (8),
in the presence or absence of each of the PLA2 inhibitors.
Figure 10 shows that carbachol activated PLD by about
2-fold, and this effect was not signiﬁcantly altered by
AACOCF3, BEL, or ONO-RS-082. In addition, we found
that 5 mM sulfasalazine, a drug used for treatment of in-
ﬂammatory bowel disease, stimulated PLD by about 2.2  
0.1-fold (mean   SEM of three independent experiments
performed in duplicate) in Raw 264.7 macrophages in the
absence of PLA2 activation, and that this effect was not sig-
niﬁcantly changed by AACOCF3, BEL, or ONO-RS-082.
Taken together, these observations suggest an involve-
ment of both cPLA2 and iPLA2 in the regulation of PLD-2
by ATP.
Effect of purinergic agonists and antagonists on the
activation of PLD by ATP
To characterize the purinergic receptors coupled to the
stimulation of PLD by ATP, the effects of several natural or
synthetic agonists and antagonists were tested. It has been
reported that synthetic Bz-ATP, an agonist that is consid-
ered to be selective for P2Z/P2X7 purinergic receptors
(51–53), is more potent than ATP in stimulating Ca2  in-
ﬂux (21), arachidonic acid release (8), or kallikrein secre-
tion in SMG cells (22). We now demonstrate that Bz-ATP,
at relatively low concentrations (100  M) potently stimu-
lates PLD in SMG acini, (Table 1) whereas a similar con-
centration of ATP does not (Fig. 1, right panel). Agonists
of other purinergic receptors were less effective or failed
to activate PLD. In particular, and unlike ATP, 1.5 mM
concentrations of the natural nucleotide triphosphates
CTP, GTP, and UTP did not cause PLD stimulation (Table
1). Adenosine (1.5 mM) was also unable to activate PLD,
and ADP (1.5 mM) was less potent than ATP or Bz-ATP in
Fig. 9. Effect of the cytosolic PLA2 inhibitors AACOCF3, (E)-
6-(bromoethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one
(bromoenol lactone) (BEL) and ONO-RS-082 on ATP-stimulated
PLD activity. SMG acini were labeled and treated as indicated in
Fig. 1, except that they were preincubated for 5 min in the absence
or in the presence of 100  M of AACOCF3 or BEL, or 500  M of
ONO-RS-082, as indicated. Cells were then treated with buffer
(open bars) or stimulated with 1.5 mM ATP (solid bars) for 30 min.
The results were calculated as a percentage of the radioactivity
present in [3H]phosphatidylethanol compared with that in total
lipids, and then expressed as the fold-stimulation relative to incuba-
tions in the absence of ATP. Results are the mean   range of two in-
dependent experiments.
Fig. 10. Lack of an effect of the cytosolic PLA2 inhibitors
AACOCF3, BEL, and ONO-RS-082 on carbachol-stimulated PLD ac-
tivity in SMG ducts. Cells were labeled and treated as indicated in
Fig. 1, except that they were preincubated for 5 min in the absence
or in the presence of 100  M of AACOCF3 or BEL, or 500  M of
ONO-RS-082, as indicated. Cells were then treated without (open
bars) or with 100  M carbachol (hatched bars) for 30 min. The re-
sults were calculated as a percentage of the radioactivity present in
[3H]phosphatidylethanol compared with that in total lipids, and
then expressed as the fold-stimulation relative to incubations in the
absence of ATP. Results are the means   range of two independent
experiments.
TABLE 1. Effect of different purinergic agonists on PLD activity
Relative PLD Activity
Control  1
CTP (1.5 mM)  1.29   0.04
GTP (1.5 mM)  0.90   0.01
UTP (1.5 mM)  0.68   0.08
ADP (1.5 mM)  2.19   0.34
Adenosin (1.5 mM)  1.20   0.14
 , -mATP (100  M)  1.00   0.19
Bz-ATP (100  M)  3.72   0.57
2MeSATP (100  M)  1.31   0.04
GTP S (100  M)  1.10   0.13
Submandibular gland (SMG) acinar cells were labeled as in Fig. 1,
and were then stimulated for 30 min with different purinergic agonists
at the concentrations that are indicated in the presence of 1% ethanol.
Phospholipase D (PLD) activity was measured by determining [3H]
phosphatidylethanol formation, as described in the Materials and
Methods section. The results were calculated as a percentage of the ra-
dioactivity present in [3H]phosphatidylethanol compared to that in to-
tal lipids, and then expressed as the fold-stimulation relative to incuba-
tions in the absence of ATP. Results are the means   SEM of three
independent experiments.1252 Journal of Lipid Research Volume 43, 2002
stimulating this enzyme activity (Table 1). Other synthetic
analogs, including  , -methylene-ATP and the P2Y puri-
nergic receptor agonist 2-methylthio-ATP (6), also failed
to increase PLD activity in the acini (Table 1). The stimu-
lation of PLD was potently inhibited by pretreatment of
the acini with oxidized ATP (o-ATP) (Fig. 11, left panel), a
selective P2Z/P2X7 receptor antagonist (8, 54), or with
suramin, a less-speciﬁc inhibitor than o-ATP but one
which can also block P2Z/P2X7 receptor activation (3)
(Fig. 11, right panel). As expected, o-ATP also inhibited
Bz-ATP-stimulated PLD (Fig. 11, left panel).
It is now recognized that the active form of ATP on
P2Z/P2X7 receptors is the free tetraionic form (ATP4 )
(1, 8, 55). Chelation of ATP by divalent cations might
therefore decrease the concentration of the active form of
ATP. It was previously demonstrated that free ATP4  drops
dramatically in the presence of 5 mM Mg2  and loses its
ability for activation of P2Z/P2X7 receptors (8). There-
fore, addition of Mg2  into the incubation medium
should also decrease PLD activation by ATP through P2Z/
P2X7 receptors. In agreement with this hypothesis, Fig. 12
shows that increasing concentrations of Mg2  block the
activation of PLD by ATP. Figure 12 also shows that Ni2 
can also inhibit ATP-stimulated PLD potently. However,
the mechanism whereby Ni2  blocks PLD activation is
rather distinct from that of Mg2 , as Ni2  ions do not de-
crease the concentration of ATP4  (8). It has been sug-
gested that Ni2  can speciﬁcally affect the P2X compo-
nent of purinergic responses by blocking Ca2  uptake by
the cells (6). Collectively, these results suggest an involve-
ment of P2Z/P2X7 receptors in the stimulation of PLD-2
by ATP. Because downregulation of PKC by PMA inhibited
the activation of PLD by ATP (Fig. 4), it might be possible
that PMA could cause a decrease in the expression of
P2Z/P2X7 receptors. In this regard, Fig. 13 shows that
PMA did not affect the expression of P2Z/P2X7 receptors
as assessed by RT-PCR.
DISCUSSION
ATP can elicit different biological actions depending
on the concentration at which it is released. At relatively
low concentrations (10–100  M), ATP stimulates P2Y1 re-
ceptors, leading to activation of PI-PLC (21, 22), whereas
at higher concentrations (0.5–1.5 mM), it stimulates P2X
Fig. 11. Effect of the P2Z/P2X7 receptor antagonists oxidized
ATP (o-ATP) and suramin on the activation of PLD by ATP. SMG
acini were labeled and treated as indicated in Fig. 1 except that
they were preincubated for 60 min in the absence (open bars) or in
the presence of 3 mM (hatched bars) of o-ATP (left panel), or for 3
min in the absence (open bars) or the presence of 3 mM (hatched
bars) or 6 mM (solid bars) of suramin (right panel). Cells were
washed once and then stimulated with 1.5 mM ATP for 30 min, as
indicated. The results were calculated as a percentage of the radio-
activity present in [3H]phosphatidylethanol compared with that in
total lipids, and then expressed as the fold-stimulation relative to in-
cubations in the absence of any addition. Results are the mean  
SEM of three independent experiments.
Fig. 12. Effect of various concentrations of Mg2  or Ni2  on the
activation of PLD by ATP. Cells were labeled and treated as indi-
cated in Fig. 1. Acini were then stimulated for 30 min with 1.5 mM
ATP in the presence of increasing concentrations of Mg2  (circles)
or Ni2  (squares). Values were calculated as a percentage of the ra-
dioactivity present in [3H]phosphatidylethanol compared with that
in total lipids. Results are the mean   SEM of three independent
experiments, except for the points at 0.25 and 0.5 mM Ni2 , where
they are the mean   range of two independent experiments.
Fig. 13. RT-PCR detection of P2Z/P2X7 mRNA in rat SMG acini
in the absence or in the presence of PMA. Total RNA (2  g) of SMG
acini incubated in the absence (lane 1) or in the presence of 500
nM PMA for 4 h (lanes 2 and 3), or vehicle ( ) was subjected to RT-
PCR, as described in Materials and Methods. RT-PCR ampliﬁcations
of  -actin mRNA were performed in parallel in the same experi-
ments as control to verify the integrity of the cDNA and the absence
of contaminating gDNA. The numbering on the right corresponds
to the size in base pairs of the amplicons. Data are representative of
three independent experiments.Pérez-Andrés et al. PLD-2 activation by ATP 1253
purinergic receptors and Ca2  inﬂux. Several reports have
implicated Ca2  in the stimulation of PLD in intact cells.
This was concluded from experiments using Ca2  iono-
phores or Ca2  mobilizing agents on a variety of cell types
(16, 41). However, the exact role of Ca2  in agonist-stimu-
lated PLD activation is not well understood. In fact, in cell
homogenates or in permeabilized cell preparations, Ca2 
is not required for activation of PLD (3, 43). Also, the abil-
ity of P2Z/P2X7 receptor agonists to stimulate PLD ac-
tivity in the transformed murine macrophage cell line
BAC1.2F5 was independent of Ca2  ions (56). ATP (10–
100  M) stimulated IP3 formation and intracellular Ca2 
mobilization in rat SMG acini, and removal of Ca2  from
the extracellular medium, or addition of EGTA, did not
suppress this response to ATP (M. Fernández, E. Pérez-
Andrés, and A. Marino, unpublished observations). Here,
we show that low concentrations of ATP do not stimulate
PLD, suggesting that generation of DAG and IP3-medi-
ated intracellular Ca2  mobilization are not sufﬁcient for
PLD activation. These observations are in agreement with
previous work on intact human lymphocytes (3), rat liver
plasma membranes, broken human neutrophils, and
permeabilized HL-60 cells [(3) and references therein],
where concentrations of Ca2  that approximated intracel-
lular values (0.1–1  M) failed to stimulate PLD. By con-
trast, at higher concentrations (0.5–1.5 mM), ATP stimu-
lated PLD activity potently in the acini. Interestingly, these
higher concentrations of ATP failed to stimulate the gen-
eration of IP3 and the subsequent mobilization of intracel-
lular Ca2 . These observations indicate that PI-PLC may
not be required for activation of PLD by ATP. However, in
rat SMG acini, PLD activation by ATP was fully dependent
on extracellular Ca2 , as removal of this cation from the
incubation medium, or addition of EGTA, completely
blocked this effect. These observations are in agreement
with those of Cabot’s group, who showed that Ca2  is not
required for bradykinin-stimulated PLD activity in subcel-
lular fractions of Madin-Darby canine kidney cells but is
necessary for the effect of this agonist in intact cells (27).
PLD activity has also been shown to be regulated by
sphingolipid metabolites. Although ceramides are potent in-
hibitors of PLD activity in a variety of cell types (13, 14, 18,
26, 28, 30–33), in human ﬁbroblasts, ceramides or sphingo-
sine can activate PLD (34). Our results indicate that it is un-
likely that PLD activation by ATP is mediated by ceramide
or its possible metabolism to sphingosine or sphingosine
1-phosphate, as ATP does not cause ceramide accumulation
in the acini. Also, the cell-permeable [C2]ceramide, exoge-
nous sphingomyelinase, or sphingosine failed to stimulate
PLD, and sphingosine 1-phosphate was a weak activator of
this enzyme activity in the acini. In addition, treatment of
the acini with [C2]ceramide or exogenous SMase blocked
PLD activation by ATP, further indicating that ceramides are
negative signals for PLD activation, as previously demon-
strated (18, 26, 28, 29, 33).
PKC plays a major role in the regulation of PLD, and in
particular of the PLD-1 isozyme, through interaction with
its N-terminus (16). As mentioned above, the involvement
of PKC in ATP-stimulated PLD was evaluated by down-reg-
ulating PKC by prolonged treatment with phorbol esters,
as they facilitate proteolysis of the enzyme at the plasma
membrane of cells (57, 58), and by using selective PKC in-
hibitors. Although PKC isoforms have different suscepti-
bility to proteolysis and to phorbol ester-induced down-
regulation (57, 58), 4 h pretreatment of the acini with
PMA rendered the acini insensitive to rapid stimulation by
PMA, and the activation of PLD by ATP was substantially
decreased. In addition, the selective PKC inhibitor chel-
erythrine inhibited ATP-stimulated PLD activity potently,
further indicating that PKC is relevant for the activation of
PLD by ATP in SMG acini.
A further objective of this work was to determine the
speciﬁc PLD isoform that was stimulated by ATP in SMG
acini. RT-PCR studies using primers speciﬁc for PLD-1 (a
and b) or PLD-2 revealed that only PLD-2 was expressed
in the acini. Our results also indicate that SMG acini lack
the oleate-dependent PLD isoform. These observations
are particularly important because the results that we have
obtained from the mechanistic studies on the regulation
of PLD by ATP can be entirely ascribed to PLD-2. Thus, we
propose that PLD-2 is regulated by PKC and Ca2  in intact
cells, and that cytosolic PLA2 activation is an important
factor in the stimulation of PLD-2 by ATP. This hypothesis
is in agreement with that of Kim et al. (50), who have sug-
gested a role for cytosolic PLA2 in the regulation of PLD-2
in different leukocyte cell lines, whereas stimulation of
PLD-1 was independent of PLA2 activation. Also, although
ATP can induce tyrosine phosphorylation of a variety of
proteins, it is unlikely that this is a major mechanism for
PLD-2 activation by ATP, as the tyrosine kinase inhibitor
genistein had no effect on this process and the tyrosine
phosphatase inhibitor vanadate did not enhance PLD acti-
vation by ATP. In support of this hypothesis, it has been
suggested that tyrosine phosphorylation of PLD-2 is im-
portant for its interaction with SH2-containing proteins
but not for activity (16). In addition, our results indicate
that PLD-2 is susceptible to inhibition by ceramides in
vivo, and that it can be activated by sphingosine 1-phos-
phate.
The stimulation of PLD by ATP that we have observed
can be mimicked by the selective P2Z/P2X7 receptor ago-
nist Bz-ATP, and is reduced by the selective antagonist
o-ATP, and suramin. Furthermore, decreasing the concen-
tration of ATP4 , which is the active form of ATP that
stimulates P2Z/P2X7 receptors, with Mg2  led to com-
plete inhibition of PLD activation. Therefore, these obser-
vations suggest that PLD-2 stimulation by ATP in rat SMG
acini may involve activation of ionotropic P2Z/P2X7 re-
ceptors. However, the inhibitory effect of o-ATP on the
ATP-stimulated PLD activity was incomplete, suggesting
that purinergic receptors other than the P2Z/P2X7 sub-
class might also be involved in this process. In this regard,
recent work from our group using RT-PCR has demon-
strated that P2X2 and P2X4 purinergic receptors are also
expressed in rat SMG acini (M. Fernández, N. Chaïb, and
A. Marino, unpublished observations). Also, it was re-
ported recently that Bz-ATP might also stimulate P2X1,
P2X3, or P2X4 receptors (59, 60), suggesting that at least1254 Journal of Lipid Research Volume 43, 2002
some of the ATP-gated channels in SMG acini might be
composed of a mixture of P2X7 and other P2X subunits.
Although Torres et al. (61) suggested that P2X7 receptors
are unlikely to form hetero-oligomeric structures, Lê et al.
(5) have reported that the native ionotropic ATP recep-
tors’ diversity most likely arises from interactions between
different P2X subunits, which generate heteromeric chan-
nels. It can thus be speculated that P2X receptors, other
than P2Z/P2X7, contribute to the activation of PLD-2 by
extracellular ATP or Bz-ATP in SMG acini.
In conclusion, we show in this work that ATP stimulates
PLD in rat SMG acini by a mechanism involving Ca2  in-
ﬂux, PKC, and cytosolic PLA2 activities, but that is inde-
pendent of intracellular Ca2  mobilization or PI-PLC acti-
vation. Most likely, the PLD isoform that is stimulated by
ATP is PLD-2, as the acini do not express PLD-1 and lack
oleate-dependent PLD activity. The results obtained with
Bz-ATP and o-ATP indicate that PLD-2 activation by ATP
may be mediated by the P2Z/P2X7 receptor, which ex-
pression is not affected by PMA. However, an involvement
of other ionotropic receptors in this process cannot be
ruled out at present. Further work is required to elucidate
whether ATP-stimulated PLD-2 is coupled to monomeric
or to heteromultimeric P2X subunits in SMG cells.
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